Central European Institute of Technology
Address: | Kamenice 753/5, 625 00 Brno, Building E35 |
---|
Phone: | +420 549 49 2911 |
---|---|
E-mail: |
Company identification number: | 00216224 |
---|---|
VAT identification number: | CZ00216224 |
Data Box ID: | 9tmj9e4 |
Bank Account: | Komerční banka, a.s., Nám. Svobody 92/21, 602 00 Brno |
---|---|
Account number/Bank ID code: 85636621/0100 | |
IBAN: CZ43 0100 0000 0000 8563 6621 | |
SWIFT (=BIC): KOMBCZPPXXX |
Total number of publications: 208
Articles
-
A Tagging Polymorphism in Fat Mass and Obesity-Associated (FTO) Gene Is Associated with Sepsis Status in Children
ROMANIAN JOURNAL OF INTERNAL MEDICINE, year: 2024, DOI
-
Adjuvant radiotherapy after brain metastasectomy: analysis of consecutive cohort of 118 patients from real world practice
Reports of Practical Oncology and Radiotherapy, year: 2024, volume: 29, edition: 1, DOI
-
Advancements in risk stratification and management strategies in primary cardiovascular prevention
Atherosclerosis, year: 2024, volume: 395, edition: August 2024, DOI
-
AlphaFind: discover structure similarity across the proteome in AlphaFold DB
Nucleic acids research, year: 2024, volume: Neuveden, edition: May 15, DOI
-
Amphipathic Helices Can Sense Both Positive and Negative Curvatures of Lipid Membranes
Journal of physical chemistry letters, year: 2024, volume: 15, edition: 1, DOI
-
An ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA inhibits PKR activation
Cell Reports, year: 2024, volume: 43, edition: 8, DOI
-
An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer
Frontiers in Oncology, year: 2024, volume: 14, edition: April 2024, DOI
-
Anticholinesterase Activity of Methanolic Extract of Amorpha fruticosa Flowers and Isolation of Rotenoids and Putrescine and Spermidine Derivatives
PLANTS-BASEL, year: 2024, volume: 13, edition: 9, DOI
-
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
New England Journal of Medicine, year: 2024, DOI
-
Blockage of BCL-XL overcomes venetoclax resistance across BCL2-positive lymphoid malignancies irrespective of BIM status
Blood advances, year: 2024, volume: 8, edition: 13, DOI